Stifel Reaffirms Buy on Marvell, $350 PT

Sep 23, 2026· Analyst: Tore Svanberg· 1 min read· Reproduced verbatim
Rating
Buy
Price target
$350
Previous
Implied upside
+36%

Stifel analyst Tore Svanberg reiterated a Buy rating and $350 price target on Marvell (NASDAQ: MRVL).

“On Tuesday, September 22, 2026, we hosted a group of investors for a booth meeting with Marvell at ECOC 2026 in Malaga, Spain, attended by Xi Wang, SVP/GM Connectivity and Russ Esmacher, SVP/GM Data Center Interconnect.

Key takeaways below…First to Sample 2nm DSPs: Marvell expects to sample 2nm products at the end of CY26, ramping C2H27, spanning PAM4 and coherent/coherent-lite modulation.

Management frames 2nm capacity, not just node access, as a durable edge.Well-Positioned Across Connectivity Topologies: Solutions span copper, pluggables, CPO, NPO, and LRO.

But as attention rotates to CPO/NPO, we think pluggables are underappreciated, with unit volume expectations increasing across scale-up, scale-out, and scale-across applications.TIA Leadership Backed by New SiGe Capacity; XPU Attach Could Exceed XPU: Marvell expanded SiGe capacity with GF, supporting TIA leadership.

Separately, XPU Attach framed as potentially larger than the XPU TAM itself, a likely focus at the Oct 6 Investor Day.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.